Clinical Trial Update: Eliquis Regulatory Post Marketing Surveillance (rPMS)

View source ↗

Summary

This update reports the completion of Eliquis (apixaban) regulatory post-marketing surveillance (rPMS). It concerns patients with venous thromboembolism and ong…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Eliquis (apixaban)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Venous Thromboembolism | Status: COMPLETED